YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Hou J, Zhang H, Liu J, Zhao Z, Wang J, Lu Z, Hu B, Zhou J, Zhao Z, Feng M, Zhang H, Shen B, Huang X, Sun B, Smyth MJ, He C, Xia Q.
Hou J, et al. Among authors: feng m.
Mol Cancer. 2019 Nov 18;18(1):163. doi: 10.1186/s12943-019-1082-3.
Mol Cancer. 2019.
PMID: 31735169
Free PMC article.